Cargando…

Serum Butyrylcholinesterase Activity: A Biomarker for Parkinson's Disease and Related Dementia

OBJECTIVE: This study aim to determine changes of serum butyrylcholinesterase (BChE) activity in PD patients and related dementia. PATIENTS AND METHODS: Consecutive PD patients and healthy controls were included and clinical data were collected. Fast serum BChE activity was determined and compared b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Mei-Xue, Xu, Xiao-Min, Hu, Ling, Liu, Yang, Huang, Yuan-Jun, Wei, You-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559914/ https://www.ncbi.nlm.nih.gov/pubmed/28840123 http://dx.doi.org/10.1155/2017/1524107

Ejemplares similares

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia
por: Kandiah, Nagaendran, et al.
Publicado: (2017)

Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression
por: Dong, Mei-Xue, et al.
Publicado: (2018)

Butyrylcholinesterase–Protein Interactions in Human Serum
por: Jasiecki, Jacek, et al.
Publicado: (2021)

Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels
por: Yang, Liu-Xue, et al.
Publicado: (2013)

Identification of Compounds for Butyrylcholinesterase Inhibition
por: Li, Shuaizhang, et al.
Publicado: (2021)

Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
por: Harrington, Carmel Therese, et al.
Publicado: (2022)

Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
por: Pezzementi, Leo, et al.
Publicado: (2011)

Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin
por: Huang, Yue-Jin, et al.
Publicado: (2008)

Correction: Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
por: Pezzementi, Leo, et al.
Publicado: (2011)

Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s Disease
por: Macdonald, Ian R., et al.
Publicado: (2017)

Identification and Study of Biomarkers from Novichok-Inhibited Butyrylcholinesterase in Human Plasma
por: Jeong, Woo-Hyeon, et al.
Publicado: (2021)

Letter to Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
por: Durner, Jürgen
Publicado: (2022)

Molecular forms of butyrylcholinesterase and obesity
por: Boberg, Dellyana R., et al.
Publicado: (2010)

Caffeine Inhibits Acetylcholinesterase, But Not Butyrylcholinesterase
por: Pohanka, Miroslav, et al.
Publicado: (2013)

Electrochemical MIP Sensor for Butyrylcholinesterase
por: Ozcelikay, Goksu, et al.
Publicado: (2019)

Time-dependent effects of storage at –80 °C on the stability of butyrylcholinesterase activity in human serum
por: Huang, Chien-Hui, et al.
Publicado: (2022)

Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach
por: Sridhar, GR, et al.
Publicado: (2005)

Letter Re: Butyrylcholinesterase is a potential biomarker for sudden infant death syndrome
por: Harrington, Carmel Therese, et al.
Publicado: (2022)

O033 Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
por: Harrington, C, et al.
Publicado: (2022)

Cerebrovascular risk factors for patients with cerebral watershed infarction: A case–control study based on computed tomography angiography in a population from Southwest China
por: Dong, Mei-Xue, et al.
Publicado: (2017)

Butyrylcholinesterase Genetic Variants: Association with Cocaine Dependence and Related Phenotypes
por: Negrão, André Brooking, et al.
Publicado: (2013)

Favorable Impact on Stress-Related Behaviors by Modulating Plasma Butyrylcholinesterase
por: Brimijoin, Stephen, et al.
Publicado: (2017)

Integrated Metabolomics and Proteomics Analysis Reveals Plasma Lipid Metabolic Disturbance in Patients With Parkinson’s Disease
por: Hu, Ling, et al.
Publicado: (2020)

Serum butyrylcholinesterase predicts survival after extracorporeal membrane oxygenation after cardiovascular surgery
por: Distelmaier, Klaus, et al.
Publicado: (2014)

Reduced Serum Butyrylcholinesterase Activity Indicates Severe Systemic Inflammation in Critically Ill Patients
por: Zivkovic, Aleksandar R., et al.
Publicado: (2015)

New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter
por: Jońca, Joanna, et al.
Publicado: (2015)

Probing the Peripheral Site of Human Butyrylcholinesterase
por: Macdonald, Ian R., et al.
Publicado: (2012)

Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
por: Pohanka, Miroslav
Publicado: (2014)

Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor
por: Sun, Shouyuan, et al.
Publicado: (2022)

The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy
por: Poetsch, Nina, et al.
Publicado: (2019)

Cholinesterase Deficiency Syndrome—A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson’s Disease
por: Arslan, Max, et al.
Publicado: (2022)

Serum Metabolomic Biomarkers of Dementia
por: Mousavi, Malahat, et al.
Publicado: (2014)

Novel Human Butyrylcholinesterase Variants: Toward Organophosphonate Detoxication
por: Dwyer, Mary, et al.
Publicado: (2014)

Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease
por: Prell, Tino, et al.
Publicado: (2019)

Does serum butyrylcholinesterase level determine the severity and mortality of COVID-19 pneumonia?: Prospective study
por: Sipahioglu, Hilal, et al.
Publicado: (2022)

Serum butyrylcholinesterase as a marker of COVID-19 mortality: Results of the monocentric prospective observational study
por: Markuskova, Lucia, et al.
Publicado: (2023)

Butyrylcholinesterase deficiency identified by preoperative patient interview
por: Lee, Serin, et al.
Publicado: (2013)

Effects of physical exercise on butyrylcholinesterase in obese adolescents
por: Silva, Isabela M.W., et al.
Publicado: (2012)

Dual inhibition of acetylcholinesterase and butyrylcholinesterase enzymes by allicin
por: Kumar, Suresh
Publicado: (2015)

Development of an in-vivo active reversible butyrylcholinesterase inhibitor
por: Košak, Urban, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g48ulaq1964gaa3dfsuhcrjoe7